BiotechTube

Atorvastatin - Cholestyramine - Sitosterol

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Symptomatic Carotid Stenosis

Conditions

Symptomatic Carotid Stenosis, Hypercholesterolemia, Indication for Carotid Endarterectomy

Trial Timeline

— → —

NCT ID
NCT01053065

About Atorvastatin - Cholestyramine - Sitosterol

Atorvastatin - Cholestyramine - Sitosterol is a pre-clinical stage product being developed by Pfizer for Symptomatic Carotid Stenosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01053065. Target conditions include Symptomatic Carotid Stenosis, Hypercholesterolemia, Indication for Carotid Endarterectomy.

What happened to similar drugs?

3 of 17 similar drugs in Symptomatic Carotid Stenosis were approved

Approved (3) Terminated (4) Active (10)
❌Sodium hyaluronate + placebo injectionDaiichi SankyoPhase 3
🔄ISV-305Sun PharmaceuticalPhase 3
🔄rabeprazole sodium + PlaceboEisaiPhase 3
🔄Esomeprazole + Matching placeboAstraZenecaPhase 3
🔄Pasireotide + OctreotideNovartisPhase 3
✅valsartanNovartisApproved
🔄Apixaban + Standard of carePfizerPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01053065Pre-clinicalCompleted

Competing Products

20 competing products in Symptomatic Carotid Stenosis

See all competitors
ProductCompanyStageHype Score
Sodium hyaluronate + placebo injectionDaiichi SankyoPhase 3
32
ISV-305Sun PharmaceuticalPhase 3
40
rabeprazole sodium + PlaceboEisaiPhase 3
40
Verinurad + Febuxostat + DapagliflozinAstraZenecaPhase 2
35
RDEA3170 + Febuxostat + BenzbromaroneAstraZenecaPhase 1/2
32
Esomeprazole + Matching placeboAstraZenecaPhase 3
40
DFV890 + PlaceboNovartisPhase 2
35
Omalizumab + Omalizumab + PlaceboNovartisPhase 2
35
Pasireotide + OctreotideNovartisPhase 3
40
TegaserodNovartisPhase 2
35
valsartanNovartisApproved
43
Epoetin biosimilarPfizerPre-clinical
26
Apixaban + Standard of carePfizerPhase 3
40
Azithromycin plus chloroquinePfizerPhase 3
32
MavacamtenBristol Myers SquibbApproved
50
Aficamten + PlaceboSanofiPhase 3
44
Vandetanib 300 mgSanofiPre-clinical
26
REGN7508 + Acetylsalicylic Acid (ASA) + PlaceboRegeneron PharmaceuticalsPhase 3
47
Rivaroxaban + PlaceboBayerPhase 3
37
Droxidopa capsules + Placebo capsulesLundbeckApproved
40